title: [The stakes of pre- and post-market authorization development and clinical assessment].
authors.affiliation: Actelion pharmaceuticals France SAS, 75001 Paris, France. Annick.schwebig@actelion.com
authors.forename: Annick
authors.initials: A
authors.lastname: Schwebig
mesh_terms: D035843:Biomedical Research / Q000331:legislation & jurisprudence / Q000379:methods; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards; D017277:Drug Approval / Q000379:methods / Q000458:organization & administration; D055808:Drug Discovery / Q000191:economics / Q000379:methods / Q000458:organization & administration; D006801:Humans; D009965:Orphan Drug Production / Q000379:methods / Q000592:standards; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards; D035583:Rare Diseases / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*